000 | 01071 a2200313 4500 | ||
---|---|---|---|
005 | 20250515135406.0 | ||
264 | 0 | _c20090205 | |
008 | 200902s 0 0 eng d | ||
022 | _a0392-856X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiedorp, M | |
245 | 0 | 0 |
_aAxonal neuropathy with prolonged sulphasalazine use. _h[electronic resource] |
260 |
_bClinical and experimental rheumatology _c |
||
300 |
_a671-2 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeurotoxicity Syndromes _xetiology |
650 | 0 | 4 |
_aPolyneuropathies _xchemically induced |
650 | 0 | 4 |
_aSpondylarthropathies _xdrug therapy |
650 | 0 | 4 |
_aSulfasalazine _xadministration & dosage |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aVoskuyl, A E | |
700 | 1 | _aVan Oosten, B W | |
773 | 0 |
_tClinical and experimental rheumatology _gvol. 26 _gno. 4 _gp. 671-2 |
|
999 |
_c18267105 _d18267105 |